Abstract-Using a bradykinin enzyme immunoassay, we measured the amount of kinin in the peritoneal washings of mice with the kaolin-induced writhing reaction. Simultaneous treatment with captopril, a kininase II inhibitor, significantly increased the kinin level at 1 min after kaolin injection.
Recently, we have developed a new pain model in mice by using the kaolin-induced writhing reaction (1) . A possible mechanism for the induction of writhing is that bradykinin could be released through the activation of factor XII by kaolin and causes the pain reaction. However direct evidence for the activation of the kallikrein-kinin system in this model has not yet demonstrated. Therefore, in this study, we measured the amount of kinin released in the peritoneal washings of mice after intraperitoneal (i.p.) injection of kaolin.
Male ICR mice (aged 5 weeks, weighing about 20 g) used were purchased from Japan SLC, Inc. (Hamamatsu, Shizuoka), and mice were intraperitoneally injected with kaolin suspension (Wako Pure Chemical Industries, Ltd.) (2.5 mg/0.5 ml saline/mouse). The writhing response was observed (early stage) as previously reported (1, 2) . The writhing reaction of later stage was induced by intra peritoneal injection of captopril (Sankyo) (20 ,og/0.2 ml saline/mouse) at 60 min after the kaolin injection as previously reported (1, 2) . In some experiment on both stages, soybean trypsin inhibitor (SBTI, Sigma) (2.5 mg/ mouse) was intraperitoneally injected simul taneously with kaolin (early stage) or with captopril (later stage).
For collection of peritoneal washings and assay of kinin, mice were sacrificed by exsanguination at 1 min after the kaolin injection (early stage) and at 5 min after the captopril injection in the later stage (60 min after kaolin injection As shown in Table 1 , kinin was detected in the peritoneal exudate 1 min after in jection of kaolin (2.5 mg/mouse, i.p.) (early stage). The amount of kinin measured at 1 min varied greatly in the different washes, but we chose this stage because the level of kinin at 5 min was markedly decreased, and in the washings obtained after 10 min, kinin could not be detected. The level of kinin at 1 min after kaolin injection was significantly suppressed by simultaneous in jection of SBTI (2.5 mg/mouse, i.p.), which is known as a plasma kallikrein inhibitor. However the kinin amount was significantly augmented by simultaneous injection of captopril (50 ag/mouse, i.p.), as a kininase II inhibitor, and this augmentation was also suppressed to the detection limit by the simultaneous injection of SBTI (2.5 mg/ mouse, i.p.) ( Table 1 ). The fact that kinin release was detected at 1 min in the peritoneal washings, whereas the writhing reaction peaked at the stage of 5-10 min, could be explained by the follows: pain receptors in the peritoneal cavity could be sensitized by serially released PGI2, after kinin production, so that a lower amount of kinin at 5-10 min could induce a further writhing reaction. Accordingly, it is suggested that there is some threshold of peritoneal kinin level for en hancing the writhing reaction, and the sensitizing action of PG12 is an indispensable factor in this reaction. Furthermore, at 60 min after kaolin in jection, the writhing reaction could be induced by intraperitoneal injection of cap topril (later stage) as previously reported (1, 2) . The kinin amount in the peritoneal washings 5 min after the captopril (20 iig/ mouse) injection was also measured and shown in Table 2 . A very small amount of kinin was found in the washings of mice that received saline only instead of captopril. The captopril-induced kinin amount was also suppressed to the assay limit by simultaneous injection of SBTI (1 mg/mouse).
The above finding is consistent with the previous report in which the captopril-induced writhing reaction (later stage) was also completely suppressed by simultaneous injection of SBTI (1, 2) .
It is well-known that kaolin induces a production of kinin by activation of the kallikrein-kinin system through activation of factor XII in mammalian plasma (6-8). Furthermore, we recently reported that the kaolin-induced writhing reaction (early  stage) and the captopril-induced writhing reaction (later stage) were completely sup pressed by pretreatment with bromelain (intravenous injection), and the mouse plasma kallikrein-kinin system was activated by incubation with kaolin in vitro (9) . Our results demonstrated that the intraperitoneal injection of kaolin produced kinin in the peritoneal cavity of the mouse, and thus the produced kinin caused the pain reaction. In addition, these results suggest that kinin released with kaolin at the early stage was rapidly degraded by kininases, although the remaining kaolin could continue to produce kinin in the peritoneal cavity of the mouse, even 60 min after the kaolin injection.
We suggested previously that the mecha nism of the kaolin-induced writhing reaction could be due to pain which may be caused by the released kinin and the sensitizing activity of PG12 that was simultaneously released by kinin, because we detected 6 keto-PGFia in the peritoneal washings and the release of 6-keto-PGFia was dependent on the activation of the kallikrein-kinin system (10) . Therefore, the above results give further proof for the mechanism of this writhing model, and this model could be useful for the evaluation of antiinflammatory and analgesic agents. 
